Product NDC 69097-0432

3 active presentations under this Product NDC family.

Review package-specific NDC rows, compare configurations, and request pricing through the RFQ workflow.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Family context

Product NDC 69097-0432 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.

  • Family size: 3 active presentations.
  • Generic family: Darifenacin Hydrobromide.
  • Primary dosage form: Tablet.
  • Common strength: 15 mg / 1.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

  • Manufacturers shown: Cipla USA Inc..
  • Dosage forms shown: Tablet.
  • Package quantities: 1000 Tablet, Extended Release, 30 Tablet, Extended Release, and 90 Tablet, Extended Release.

Manufacturer pathways

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Showing page 1 of 1
Darifenacin Hydrobromide 15 mg / 1 Tablet 1000 Tablet, Extended Release69097-0432-1515 mg / 1Tablet1000 Tablet, Extended Release
Darifenacin Hydrobromide 15 mg / 1 Tablet 30 Tablet, Extended Release69097-0432-0215 mg / 1Tablet30 Tablet, Extended Release
Darifenacin Hydrobromide 15 mg / 1 Tablet 90 Tablet, Extended Release69097-0432-0515 mg / 1Tablet90 Tablet, Extended Release

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.